首页> 中文期刊> 《中国医学创新》 >奥美拉唑与抗生素联合治疗30例慢性胃炎的疗效及其安全性

奥美拉唑与抗生素联合治疗30例慢性胃炎的疗效及其安全性

         

摘要

Objective:To investigate the efficacy and safety of omeprazole and antibiotics in treatment of chronic gastritis.Method:A total of 60 cases,of chronic gastritis patients were selected and they were randomly divided into control group(n=30)and observation group(n=30).Control group was given clarithromycin therapy,while observation group was given omeprazole and clarithromycin therapy.Clinical symptoms,overall treatment efficiency and the rate of adverse reactions in the two groups were compared.Result:The total efficiency of observation group was 96.67%,while control group was 73.33%,there was a significant different between the two group(P<0.05).The adverse reaction rate of two groups had no significant difference(P>0.05).Conclusion:Omeprazole and clarithromycin is effective with less adverse reaction,and is worthy of promoting.%目的:探讨奥美拉唑和抗生素联合治疗慢性胃炎的疗效及其安全性。方法:60例慢性胃炎的患者随机分为对照组(n=30)和观察组(n=30)。给予对照组单独口服克拉霉素治疗,给予观察组奥美拉唑和克拉霉素联合治疗,对比两组的临床症状改善情况、治疗效果及不良反应发生情况。结果:治疗后,观察组的治疗总有效率为96.67%,对照组的治疗总有效率为73.33%,两组比较差异有统计学意义(P<0.05);观察组出现的不良反应率和对照组相比,差异无统计学意义(P>0.05)。结论:奥美拉唑和克拉霉素联合治疗的效果确切,不良反应少,值得推广。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号